Scholarlink

Background <p>Silver nanoparticles (AgNPs) are increasingly employed across diverse applications, raising concerns regarding their potential biosafety risks. The liver plays a pivotal role as a target organ upon exposure to AgNPs. The adverse outcome pathway (AOP) framework provides a structured, mechanism-based approach for assessing and managing toxicological risks.</p> Results <p>In this study, we applied the AOP framework to construct a mechanistic relationship map of AgNP-induced hepatotoxicity. Using in vitro (HepG2 cells) and in vivo (C57BL/6 mice) models, we identified mitochondrial dysfunction as a molecular initiating event (MIE), characterized by excessive dynamin-related protein 1 (DRP1)-mediated mitochondrial fission and increased mitochondrial reactive oxygen species (mtROS), which serve as key events (KEs). The cascade ultimately leads to programmed cell death and structural/functional liver injury, which constitute the AO. Further mechanistic investigations revealed that DRP1 phosphorylation at the Ser616 site activated sequestration 1 (p62)/PTEN-induced kinase 1 (PINK1)-dependent mitophagy, which partially mitigated the severity of the AO by preserving mitochondrial integrity and reducing oxidative damage.</p> Conclusion <p>These findings not only demonstrate the critical role of DRP1 activation in linking mitochondrial dynamics to hepatocellular ferroptosis, but also highlight the value of the AOP framework as a tool for predicting NPs risk assessment and regulatory decision-making.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Adverse outcome pathway analysis identifies DRP1-driven mitochondrial dysfunction as a central event in silver nanoparticle-induced hepatocyte ferroptosis

  • 期刊论文

  • 发表日期：

    2026年3月19日

查看全文
  • Jiangyan Li,
  • Jiaqi Lan,
  • Zhiwen Liu,
  • Yujia Zhang,
  • Zhuang Duan,
  • Xinyue Wang,
  • Zhijun Geng,
  • Bao Zhao,
  • Hezuo Lü,
  • Qiang Fang,
  • Fengchao Wang

摘要

Background

Silver nanoparticles (AgNPs) are increasingly employed across diverse applications, raising concerns regarding their potential biosafety risks. The liver plays a pivotal role as a target organ upon exposure to AgNPs. The adverse outcome pathway (AOP) framework provides a structured, mechanism-based approach for assessing and managing toxicological risks.

Results

In this study, we applied the AOP framework to construct a mechanistic relationship map of AgNP-induced hepatotoxicity. Using in vitro (HepG2 cells) and in vivo (C57BL/6 mice) models, we identified mitochondrial dysfunction as a molecular initiating event (MIE), characterized by excessive dynamin-related protein 1 (DRP1)-mediated mitochondrial fission and increased mitochondrial reactive oxygen species (mtROS), which serve as key events (KEs). The cascade ultimately leads to programmed cell death and structural/functional liver injury, which constitute the AO. Further mechanistic investigations revealed that DRP1 phosphorylation at the Ser616 site activated sequestration 1 (p62)/PTEN-induced kinase 1 (PINK1)-dependent mitophagy, which partially mitigated the severity of the AO by preserving mitochondrial integrity and reducing oxidative damage.

Conclusion

These findings not only demonstrate the critical role of DRP1 activation in linking mitochondrial dynamics to hepatocellular ferroptosis, but also highlight the value of the AOP framework as a tool for predicting NPs risk assessment and regulatory decision-making.